Rapid Diagnostic Kit Market, Point of Care Testing Devices Market, Europe Point of Care Testing Devices Industry, Growth, Size : Ken Research

1

• Europe POCT Devices Market Outlook to 2022 Ken
  Research

2

• The report titled Europe POCT Devices Market
  Outlook to 2022 - by Geography (Western Europe
  Eastern Europe), by Product (Blood Glucose POCT,
  Infectious POCT, Cardiac POCT, Rapid Coagulation
  POCT, Blood Gas Electrolytes POCT, Hematology
  POCT, Pregnancy POCT, Urinalysis POCT,
  Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT
  Drugs of Abuse POCT), by Customer Segments
  (Hospitals Clinics, Diagnostics Labs Primary
  Care Units and Homecare Patients) provides a
  comprehensive analysis of Europe POCT devices
  market evolution and overview, market ecosystem,
  market nature, value chain entity analysis
  (OEMs, CF agents, distributors, retailers
  customers), market size, and market segments by
  Geography (Western Europe Eastern Europe), by
  Product (Blood Glucose POCT, Infectious POCT,
  Cardiac POCT, Rapid Coagulation POCT, Blood Gas
  Electrolytes POCT, Hematology POCT, Pregnancy
  POCT, Urinalysis POCT, Cholesterol POCT, Fecal
  Occult POCT, Hb1Ac POCT Drugs of Abuse POCT),
  by Customer Segments (Hospitals Clinics,
  Diagnostics Labs Primary Care Units and
  Homecare Patients) and by Instruments and
  Consumables. Competition landscape, competition
  nature, major competition parameters and market
  share of major companies along with company
  profiles of Alere, Roche Holding AG, Siemens
  Healthineers, Becton Dickinson, Sysmex
  Corporation, EKF Diagnostics Holding, PTS
  Diagnostics, Werfen, Danaher Corporation, A.
  Menarini Diagnostics, Trinity Biotech, FujiFilm
  and others have been profoundly covered in the
  report. The report underscores prevailing
  government rules and regulation along with
  analyst recommendation to highlight the major
  opportunities and cautions.
• The report is useful for POCT Devices
  manufacturers, distributors, retailers, potential
  entrants and other stakeholders to align their
  market centric strategies according to ongoing
  and expected trends in the future.

3
Europe POCT Devices Market Size and Overview

• Market Size Europe POCT Devices Market has grown
  registering a robust CAGR of close to 8 during
  the review period. Currently, the market is in
  growth stage with high potential of future
  expansion in both developed and developing
  countries of the region. Various factors
  supporting growth include high incidence of
  chronic diseases, rising health awareness,
  medical advancement in POCT sector, advancement
  in medical knowledge and RD work, unease
  associated with laboratory testing methods and
  new companies venturing the market. Increase in
  urban population especially in the metro-cities
  which has been the largest end-user segment of
  the market and higher spending on RD activities
  by the companies has led to the rise in number of
  point of care testing devices customer
  interest. A substantial increase in awareness
  amongst population in cities smaller towns has
  provided major thrust to this market. In
  parallel, growth popularity of pregnancy blood
  glucose POCT and advancement in technologies have
  given rise to new and improved devices. Advent of
  deadly infectious and cardiac diseases has led
  people to use these devices for quick detection.
  However, the market has been flooded with fake
  products, found all throughout the value chain.

4
Market Segmentation

• By Geography Western Europe has led the overall
  European scenario in terms of sales of POCT
  devices in 2017. Advanced medical infrastructure,
  higher level of disposable income of people,
  higher awareness and spending on healthcare,
  presence of well established manufacturers and
  government support has enabled countries such as
  the Germany, Italy and UK to lead the overall
  European landscape in terms of both, sales and
  demand in the review period.
• By Product Blood Glucose POCT devices led the
  market with highest sales revenue in 2017. The
  devices are used on routine basis to monitor
  glucose levels for people at home or for patients
  under tight glycemic control requirements. This
  segment was followed by Infectious, Cardiac,
  Rapid Coagulation, Blood Gas and Electrolytes,
  Hematology, Pregnancy POCT, Urinalysis POCT,
  Cholesterol Fecal Occult, Drugs of Abuse and
  Hb1Ac POCT devices respectively.
• By Customer Segment Hospitals and Clinics have
  been the largest customers of POCT devices in
  Europe in 2017. The entity uses these devices for
  diagnostics, treatment, monitoring and rapid
  testing. The tests carried out consists of TB,
  HIV, Malaria, Syphilis, Dengue, Strep A, HBV, C
  Diff, CD, 4, HCV, MRSA, Flu, UTI, Viral and
  others. Diagnostic labs and primary care units
  constitute for second largest share in the
  market. Home care and patients occupied lowest
  share owing to low volume sales and low
  replacement demand. Major motive to buy a POCT
  device for home patients is self assessment
  referral and cost reduction.

5

• By Instruments and Consumables Instruments
  comprise of an apparatus or a machine that is
  used in the diagnosis of an illness or disease,
  or for detecting, measuring, restoring,
  correcting or modifying the structure or function
  of the body for some health purpose. Consumables
  primarily comprise of strip based instruments
  such as Electrochemical or reflectance
  strip-based glucose meters and INR analyzers.
  HbA1c, Pregnancy, Cholesterol and Drug of Abuse
  POCT devices utilize consumables in large scale
  for diagnostics.
• Competitive Landscape
• Competition in the market has been concentrated
  among 6 major 10-15 smaller companies in 2017.
  These include Radiometer, Werfen, Siemens, Roche,
  Nova, Alere and others. Major competition is
  being driven through new product launches,
  innovation and marketing initiatives. Products
  are being manufactured domestically as well as
  imported.

6

• Future Outlook and Tailwind
• Market has been anticipated to showcase a
  substantial growth at a CAGR of close to 6
  during the forecast period. Increase in the
  number of new entrants in the market, larger
  product acceptance, new product launches,
  expanding distribution channels of existing
  players and higher marketing expenditure done by
  the companies are expected to be tailwind for
  future growth.

7

• For more information on the research report,
  refer to below link
• https//www.kenresearch.com/healthcare/medical-dev
  ices/europe-poct-devices-market/149664-91.html
• Related Reports-
• https//www.kenresearch.com/healthcare/medical-dev
  ices/medical-equipment-and-devices-market-research
  -report/119-91.html
• https//www.kenresearch.com/healthcare/medical-dev
  ices/vietnam-medical-devices-market/143604-91.html
  
• https//www.kenresearch.com/healthcare/medical-dev
  ices/indonesia-medical-devices-market/143545-91.ht
  ml
• https//www.kenresearch.com/healthcare/medical-dev
  ices/global-robotic-surgery-market/142287-91.html
• Contact UsKen ResearchAnkur Gupta, Head
  Marketing Communicationssales_at_kenresearch.com
• 91-9015378249

8
(No Transcript)